Enveric Biosciences (ENVB) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $1.38, -0.72% vs the prior close of $1.39.
- Volume 22.52K shares, 0.3x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
ENVB dips 0.7% to $1.38. Closed at $1.38, -0.72% vs the prior close of $1.39. Day range $1.35–$1.44, opened at $1.35.
ENVB daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — ENVB dips 0.7% to $1.38
- Closed at $1.38, -0.72% vs the prior close of $1.39. Day range $1.35–$1.44, opened at $1.35.
- Volume was 22.52K shares, 0.3x its 50-day average of 88.51K — lighter than usual.
- Price is -5.6% vs its 50-day average ($1.46) and -35.6% vs its 200-day average ($2.14).
- 52-week range $1.17–$13.25; today's close sits at 2% of that range, 89.6% below the 52-week high.
Oct 15, 2026 — ENVB rises 1.5% to $1.39
- Closed at $1.39, +1.46% vs the prior close of $1.37. Day range $1.35–$1.44, opened at $1.37.
- Volume was 21.20K shares, 0.2x its 50-day average of 96.38K — lighter than usual.
- Price is -5.1% vs its 50-day average ($1.47) and -35.6% vs its 200-day average ($2.16).
- 52-week range $1.17–$13.25; today's close sits at 2% of that range, 89.5% below the 52-week high.
Oct 14, 2026 — ENVB dips 2.1% to $1.37, a 1-month low
- Closed at $1.37, -2.14% vs the prior close of $1.40. Day range $1.33–$1.45, opened at $1.38.
- Volume was 162.80K shares, 1.7x its 50-day average of 96.08K.
- Price is -6.9% vs its 50-day average ($1.47) and -36.8% vs its 200-day average ($2.17).
- 52-week range $1.17–$13.25; today's close sits at 2% of that range, 89.7% below the 52-week high.
Oct 13, 2026 — ENVB slides 4.8% to $1.40, a 1-month low
- Closed at $1.40, -4.76% vs the prior close of $1.47. Day range $1.38–$1.49, opened at $1.43.
- Volume was 102.10K shares, 1.1x its 50-day average of 95.74K.
- Price is -5.2% vs its 50-day average ($1.48) and -35.8% vs its 200-day average ($2.18).
- 52-week range $1.17–$13.25; today's close sits at 2% of that range, 89.4% below the 52-week high.
Oct 12, 2026 — ENVB rises 1.4% to $1.47
- Closed at $1.47, +1.38% vs the prior close of $1.45. Day range $1.40–$1.52, opened at $1.43.
- Volume was 114.60K shares, 1.2x its 50-day average of 95.02K.
- Price is -0.8% vs its 50-day average ($1.48) and -33.1% vs its 200-day average ($2.20).
- 52-week range $1.17–$13.25; today's close sits at 2% of that range, 88.9% below the 52-week high.
Oct 9, 2026 — ENVB slides 4.6% to $1.45
- Closed at $1.45, -4.61% vs the prior close of $1.52. Day range $1.44–$1.50, opened at $1.48.
- Volume was 50.20K shares, 0.5x its 50-day average of 95.38K — lighter than usual.
- Price is -2.3% vs its 50-day average ($1.48) and -34.5% vs its 200-day average ($2.21).
- 52-week range $1.17–$13.25; today's close sits at 2% of that range, 89.1% below the 52-week high.
Oct 8, 2026 — ENVB rises 1.7% to $1.52
- Closed at $1.52, +1.67% vs the prior close of $1.50. Day range $1.46–$1.53, opened at $1.47.
- Volume was 64.90K shares, 0.7x its 50-day average of 98.27K.
- Price is +2.5% vs its 50-day average ($1.48) and -31.9% vs its 200-day average ($2.23).
- 52-week range $1.17–$13.25; today's close sits at 3% of that range, 88.5% below the 52-week high.
Oct 7, 2026 — ENVB rises 1.7% to $1.50
- Closed at $1.50, +1.70% vs the prior close of $1.47. Day range $1.45–$1.51, opened at $1.45.
- Volume was 41.40K shares, 0.4x its 50-day average of 99.65K — lighter than usual.
- Price is +1.1% vs its 50-day average ($1.48) and -33.6% vs its 200-day average ($2.25).
- 52-week range $1.17–$13.25; today's close sits at 3% of that range, 88.7% below the 52-week high.
Oct 6, 2026 — ENVB dips 2.6% to $1.47
- Closed at $1.47, -2.65% vs the prior close of $1.51. Day range $1.43–$1.53, opened at $1.53.
- Volume was 51.00K shares, 0.5x its 50-day average of 101.31K — lighter than usual.
- Price is -0.4% vs its 50-day average ($1.48) and -35.2% vs its 200-day average ($2.27).
- 52-week range $1.17–$13.25; today's close sits at 2% of that range, 88.9% below the 52-week high.
Oct 5, 2026 — ENVB rises 2.0% to $1.51
- Closed at $1.51, +2.03% vs the prior close of $1.48. Day range $1.45–$1.53, opened at $1.46.
- Volume was 54.30K shares, 0.5x its 50-day average of 102.37K — lighter than usual.
- Price is +2.5% vs its 50-day average ($1.47) and -34.0% vs its 200-day average ($2.29).
- 52-week range $1.17–$13.25; today's close sits at 3% of that range, 88.6% below the 52-week high.
Oct 2, 2026 — ENVB rises 1.4% to $1.48
- Closed at $1.48, +1.37% vs the prior close of $1.46. Day range $1.46–$1.53, opened at $1.51.
- Volume was 72.90K shares, 0.7x its 50-day average of 103.28K.
- Price is +0.8% vs its 50-day average ($1.47) and -35.9% vs its 200-day average ($2.31).
- 52-week range $1.17–$13.25; today's close sits at 3% of that range, 88.8% below the 52-week high.
ENVB latest news & SEC filings
Every SEC filing by or about ENVB in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Aug 14, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$3.03M (prior year -$2.52M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.76 (prior year -$11.65) (loss narrowed vs Jun 30, 2025)
Aug 14, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 14, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 13, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Things to know before you trade ENVB
- Last results release: Aug 14, 2026 (8-K Item 2.02). Previous ones: May 15, 2026, Mar 27, 2026, Nov 14, 2025. Based on that rhythm, the next report is likely around Nov 13, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.14% (largest 4.8%).
- Liquidity: about 66.65K shares (≈$91.97K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $1.38 vs a range of $1.17–$13.25 (2% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:12 on Oct 28, 2025, 1:15 on Jan 29, 2025, 1:15 on Jan 27, 2025
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 10-Q Aug 14, 2026; 8-K Aug 14, 2026; 8-K Jun 9, 2026.
- Share count: 4.48M shares outstanding (Aug 12, 2026), +37.9% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
ENVB market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 1.35 | 1.44 | 1.35 | 1.38 | 22.52K |
| Oct 15, 2026 | 1.37 | 1.44 | 1.35 | 1.39 | 21.20K |
| Oct 14, 2026 | 1.38 | 1.45 | 1.33 | 1.37 | 162.80K |
| Oct 13, 2026 | 1.43 | 1.49 | 1.38 | 1.40 | 102.10K |
| Oct 12, 2026 | 1.43 | 1.52 | 1.40 | 1.47 | 114.60K |
| Oct 9, 2026 | 1.48 | 1.50 | 1.44 | 1.45 | 50.20K |
| Oct 8, 2026 | 1.47 | 1.53 | 1.46 | 1.52 | 64.90K |
| Oct 7, 2026 | 1.45 | 1.51 | 1.45 | 1.50 | 41.40K |
| Oct 6, 2026 | 1.53 | 1.53 | 1.43 | 1.47 | 51.00K |
| Oct 5, 2026 | 1.46 | 1.53 | 1.45 | 1.51 | 54.30K |
| Oct 2, 2026 | 1.51 | 1.53 | 1.46 | 1.48 | 72.90K |
| Oct 1, 2026 | 1.46 | 1.48 | 1.41 | 1.46 | 83.60K |
| Sep 30, 2026 | 1.44 | 1.53 | 1.42 | 1.49 | 57.10K |
| Sep 29, 2026 | 1.46 | 1.48 | 1.42 | 1.45 | 45.80K |
| Sep 28, 2026 | 1.51 | 1.56 | 1.45 | 1.47 | 54.60K |
| Sep 25, 2026 | 1.52 | 1.53 | 1.48 | 1.50 | 38.20K |
| Sep 24, 2026 | 1.57 | 1.58 | 1.48 | 1.54 | 84.70K |
| Sep 23, 2026 | 1.58 | 1.60 | 1.52 | 1.57 | 113.40K |
| Sep 22, 2026 | 1.54 | 1.61 | 1.52 | 1.54 | 46.30K |
| Sep 21, 2026 | 1.64 | 1.65 | 1.55 | 1.56 | 51.30K |
About Enveric Biosciences
Enveric Biosciences (ENVB) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in CAMBRIDGE, MA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 890821.
ENVB board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Sheila Dewitt | Director | Jun 3, 2026 |
| George A. Kegler | Director | Jun 3, 2026 |
| Frank Pasqualone | Director | Jun 3, 2026 |
| Marcus Schabacker | Director | Jun 3, 2026 |
| Joseph Edward Tucker | Chief Executive Officer | Jun 3, 2026 |
| Michael D Webb | Director | Jun 3, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Kevin Michael Coveney | Chief Financial Officer | Jun 3, 2026 |
| Peter J. Facchini | Chief Innovation Officer | Jun 3, 2026 |
| Joseph Edward Tucker | Chief Executive Officer | Jun 3, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
ENVB financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-8.77M | -36.24 | $-8.14M |
| Dec 31, 2024 | — | $-9.57M | -228.48 | $-7.73M |
| Dec 31, 2023 | — | $-17.29M | -121.29 | $-14.09M |
| Dec 31, 2022 | — | $-18.47M | -13.00 | $-17.15M |
| Dec 31, 2021 | — | $-48.98M | — | $-11.46M |
Latest balance sheet: total assets $8.94M, total liabilities $4.00M, cash $2.84M (as of Jun 30, 2026).
ENVB earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 14, 2026 | 8-K Item 2.02 (results) | $1.53 |
| May 15, 2026 | 8-K Item 2.02 (results) | $2.25 |
| Mar 27, 2026 | 8-K Item 2.02 (results) | $1.88 |
| Nov 14, 2025 | 8-K Item 2.02 (results) | $5.28 |
| Aug 14, 2025 | 8-K Item 2.02 (results) | $13.32 |
| May 14, 2025 | 8-K Item 2.02 (results) | $15.72 |
| Mar 31, 2025 | 8-K Item 2.02 (results) | $16.68 |
| Nov 14, 2024 | 8-K Item 2.02 (results) | $1,071.90 |
| Aug 12, 2024 | 8-K Item 2.02 (results) | — |
| May 15, 2024 | 8-K Item 2.02 (results) | — |
| Mar 26, 2024 | 8-K Item 2.02 (results) | — |
| Nov 13, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on ENVB
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.